Design of an implantable active microport system for patient specific drug release

被引:18
作者
Geipel, A. [1 ]
Goldschmidtboeing, F. [1 ]
Jantscheff, P. [2 ]
Esser, N. [2 ]
Massing, U. [2 ]
Woias, P. [1 ]
机构
[1] Univ Freiburg, Lab Design Microsyst, Dept Microsyst Engn IMTEK, D-79110 Freiburg, Germany
[2] Tumor Biol Ctr, Dept Clin Res, Freiburg, Germany
关键词
drug delivery; infusion systems; micropump; electronic medical devices;
D O I
10.1007/s10544-007-9147-2
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We present a novel concept of an implantable active microport based on micro technology that incorporates a high-resolution volumetric dosing unit and a drug reservoir into the space of a conventional subcutaneous port. The controlled release of small drug volumes from such an "active microport" is crucial e.g. for innovative methods in cancer treatment or pain therapy. Our microport system delivers a flow rate in the range of 10-1,000 mu l/h and enables a patient-specific release profile. The core of our device is a two-stage piezoelectric micropump. It features a backpressure-independent volumetric dosing capability i.e. a stable flow rate is ensured up to a backpressure of 30 kPa. The stroke volume and hence the resolution of the mircopump is voltage controlled and can be preset between 10 and 200 nl. A miniaturized high-performance electronic control unit enables freely programmable dosing profiles. This electronic circuit is optimized for both energy consumption and weight which are both essential for a portable device. The data of an implemented pressure sensor are used to permanently monitor the dosing process and to detect a potential catheter occlusion. A polyurethane soft lithography process is introduced for the fabrication of the prototype. Therewith, a compact multilayer system has been developed which measures only 50x35x25 mm(3).
引用
收藏
页码:469 / 478
页数:10
相关论文
共 34 条
[1]   VENOUS PRESSURE-VOLUME RELATION AND CALF BLOOD-FLOW DETERMINED BY CHANGES IN POSTURE [J].
BARENDSEN, GJ ;
VANDENBERG, J .
CARDIOVASCULAR RESEARCH, 1976, 10 (02) :206-213
[2]  
Bocci G, 2002, CANCER RES, V62, P6938
[3]   Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data [J].
de Hoon, JNJM ;
Poppe, KA ;
Thijssen, HHW ;
Struijker-Boudier, HAJ ;
Van Bortel, LMAB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (01) :45-51
[4]   Nanopore Technology for Biomedical Applications [J].
Desai, Tejal A. ;
Hansford, Derek J. ;
Kulinsky, Lawrence ;
Nashat, Amir H. ;
Rasi, Guido ;
Tu, Jay ;
Wang, Yuchun ;
Zhang, Miqin ;
Ferrari, Mauro .
BIOMEDICAL MICRODEVICES, 1999, 2 (01) :11-40
[5]   Low temperature plasma-assisted wafer bonding and bond-interface stress characterization [J].
Doll, A ;
Goldschmidtboeing, F ;
Woias, P .
MEMS 2004: 17TH IEEE INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL SYSTEMS, TECHNICAL DIGEST, 2004, :665-668
[6]  
Drevs J, 2004, ANTICANCER RES, V24, P1759
[7]  
EVANS AT, 2007, P TRANSD 07 LYON FRA, P359
[8]  
FERRARA LA, 1987, INT J CLIN PHARM RES, V7, P463
[9]   Cancer nanotechnology: Opportunities and challenges [J].
Ferrari, M .
NATURE REVIEWS CANCER, 2005, 5 (03) :161-171
[10]  
Geipel A, 2007, Proceedings of the Fifth IASTED International Conference on Biomedical Engineering, P272